So Anthropic is doing drug design, and my feed is now full of jaded bio folks declaring what a terrible idea this is.
"Drug design is hard" / "don't compete with your customers" / "if they were serious they'd be acquiring Cradle, Boltz" / etc
I disagree + I am SO EXCITED.
1/2
Positive users view Anthropic's entry into drug design as an optimistic new start despite early challenges, while negative users argue the effort will fail without hiring biology experts like DeepMind did.
No Digg Deeper questions have been answered for this story yet.
Yes it'll be hard. Yes they're starting from years behind AIxBio SOTA. Yes they'll have to learn difficult lessons.
But also maybe this is the start of something amazing. I am enthusiastic to see capable folks passionate about solving the exact same problems I care about.🎉
2/2
So Anthropic is doing drug design, and my feed is now full of jaded bio folks declaring what a terrible idea this is.
"Drug design is hard" / "don't compete with your customers" / "if they were serious they'd be acquiring Cradle, Boltz" / etc
I disagree + I am SO EXCITED.
1/2
@PatrickKidger The problem is, unless they hire biology experts as e.g deepmind did, they are not capable...